nodes	percent_of_prediction	percent_of_DWPC	metapath
Carglumic Acid—CPS1—Urea cycle and metabolism of amino groups—SRM—multiple sclerosis	0.212	0.769	CbGpPWpGaD
Carglumic Acid—CPS1—retina—multiple sclerosis	0.0602	0.222	CbGeAlD
Carglumic Acid—CPS1—medulla oblongata—multiple sclerosis	0.0435	0.16	CbGeAlD
Carglumic Acid—CPS1—midbrain—multiple sclerosis	0.0398	0.147	CbGeAlD
Carglumic Acid—CPS1—spinal cord—multiple sclerosis	0.0388	0.143	CbGeAlD
Carglumic Acid—CPS1—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.0354	0.128	CbGpPWpGaD
Carglumic Acid—CPS1—nervous system—multiple sclerosis	0.0327	0.12	CbGeAlD
Carglumic Acid—CPS1—central nervous system—multiple sclerosis	0.0315	0.116	CbGeAlD
Carglumic Acid—CPS1—brain—multiple sclerosis	0.025	0.0921	CbGeAlD
Carglumic Acid—Tonsillitis—Mitoxantrone—multiple sclerosis	0.022	0.0503	CcSEcCtD
Carglumic Acid—Aminolevulinic acid—SLC15A2—multiple sclerosis	0.0146	1	CrCbGaD
Carglumic Acid—Ear infection—Triamcinolone—multiple sclerosis	0.00987	0.0225	CcSEcCtD
Carglumic Acid—Influenza—Fingolimod—multiple sclerosis	0.00936	0.0214	CcSEcCtD
Carglumic Acid—Weight decreased—Fingolimod—multiple sclerosis	0.00847	0.0193	CcSEcCtD
Carglumic Acid—Pneumonia—Fingolimod—multiple sclerosis	0.0084	0.0192	CcSEcCtD
Carglumic Acid—Infestation NOS—Fingolimod—multiple sclerosis	0.00835	0.0191	CcSEcCtD
Carglumic Acid—Infestation—Fingolimod—multiple sclerosis	0.00835	0.0191	CcSEcCtD
Carglumic Acid—Haemoglobin decreased—Mitoxantrone—multiple sclerosis	0.00808	0.0185	CcSEcCtD
Carglumic Acid—Bradycardia—Fingolimod—multiple sclerosis	0.00763	0.0174	CcSEcCtD
Carglumic Acid—Cardiac disorder—Fingolimod—multiple sclerosis	0.00695	0.0159	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—SRM—multiple sclerosis	0.00649	0.0235	CbGpPWpGaD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00552	0.0126	CcSEcCtD
Carglumic Acid—Infection—Fingolimod—multiple sclerosis	0.00529	0.0121	CcSEcCtD
Carglumic Acid—Nervous system disorder—Fingolimod—multiple sclerosis	0.00522	0.0119	CcSEcCtD
Carglumic Acid—Skin disorder—Fingolimod—multiple sclerosis	0.00517	0.0118	CcSEcCtD
Carglumic Acid—Sweating increased—Cladribine—multiple sclerosis	0.00517	0.0118	CcSEcCtD
Carglumic Acid—Pneumonia—Cladribine—multiple sclerosis	0.00476	0.0109	CcSEcCtD
Carglumic Acid—Infestation NOS—Cladribine—multiple sclerosis	0.00473	0.0108	CcSEcCtD
Carglumic Acid—Infestation—Cladribine—multiple sclerosis	0.00473	0.0108	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.0046	0.0105	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—CYP27B1—multiple sclerosis	0.00457	0.0166	CbGpPWpGaD
Carglumic Acid—CPS1—Metabolism—CYP24A1—multiple sclerosis	0.00457	0.0166	CbGpPWpGaD
Carglumic Acid—CPS1—Metabolism—GPC5—multiple sclerosis	0.00418	0.0152	CbGpPWpGaD
Carglumic Acid—Cardiac disorder—Cladribine—multiple sclerosis	0.00394	0.00901	CcSEcCtD
Carglumic Acid—Pneumonia—Azathioprine—multiple sclerosis	0.00387	0.00884	CcSEcCtD
Carglumic Acid—Infestation NOS—Azathioprine—multiple sclerosis	0.00385	0.00879	CcSEcCtD
Carglumic Acid—Infestation—Azathioprine—multiple sclerosis	0.00385	0.00879	CcSEcCtD
Carglumic Acid—Asthenia—Fingolimod—multiple sclerosis	0.00382	0.00873	CcSEcCtD
Carglumic Acid—Malnutrition—Cladribine—multiple sclerosis	0.0037	0.00845	CcSEcCtD
Carglumic Acid—Diarrhoea—Fingolimod—multiple sclerosis	0.00364	0.00832	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—RRM1—multiple sclerosis	0.00347	0.0126	CbGpPWpGaD
Carglumic Acid—Anaemia—Cladribine—multiple sclerosis	0.00342	0.00781	CcSEcCtD
Carglumic Acid—Sweating increased—Mitoxantrone—multiple sclerosis	0.0034	0.00776	CcSEcCtD
Carglumic Acid—Headache—Fingolimod—multiple sclerosis	0.00334	0.00762	CcSEcCtD
Carglumic Acid—Weight decreased—Mitoxantrone—multiple sclerosis	0.00316	0.00721	CcSEcCtD
Carglumic Acid—Pneumonia—Mitoxantrone—multiple sclerosis	0.00313	0.00715	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00313	0.00714	CcSEcCtD
Carglumic Acid—Infection—Cladribine—multiple sclerosis	0.003	0.00685	CcSEcCtD
Carglumic Acid—Nervous system disorder—Cladribine—multiple sclerosis	0.00296	0.00676	CcSEcCtD
Carglumic Acid—Skin disorder—Cladribine—multiple sclerosis	0.00293	0.0067	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Cladribine—multiple sclerosis	0.00292	0.00666	CcSEcCtD
Carglumic Acid—Anorexia—Cladribine—multiple sclerosis	0.00288	0.00657	CcSEcCtD
Carglumic Acid—Bradycardia—Mitoxantrone—multiple sclerosis	0.00284	0.00649	CcSEcCtD
Carglumic Acid—Sweating increased—Prednisolone—multiple sclerosis	0.00279	0.00637	CcSEcCtD
Carglumic Acid—Anaemia—Azathioprine—multiple sclerosis	0.00278	0.00635	CcSEcCtD
Carglumic Acid—Somnolence—Cladribine—multiple sclerosis	0.00268	0.00613	CcSEcCtD
Carglumic Acid—Influenza—Triamcinolone—multiple sclerosis	0.00263	0.00601	CcSEcCtD
Carglumic Acid—Decreased appetite—Cladribine—multiple sclerosis	0.00262	0.00599	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00261	0.00595	CcSEcCtD
Carglumic Acid—Sweating increased—Triamcinolone—multiple sclerosis	0.00256	0.00586	CcSEcCtD
Carglumic Acid—Sweating increased—Methylprednisolone—multiple sclerosis	0.00256	0.00584	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00254	0.00581	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00247	0.00564	CcSEcCtD
Carglumic Acid—Infection—Azathioprine—multiple sclerosis	0.00244	0.00557	CcSEcCtD
Carglumic Acid—Body temperature increased—Cladribine—multiple sclerosis	0.00239	0.00545	CcSEcCtD
Carglumic Acid—Abdominal pain—Cladribine—multiple sclerosis	0.00239	0.00545	CcSEcCtD
Carglumic Acid—Skin disorder—Azathioprine—multiple sclerosis	0.00238	0.00544	CcSEcCtD
Carglumic Acid—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00238	0.00544	CcSEcCtD
Carglumic Acid—Infestation NOS—Methylprednisolone—multiple sclerosis	0.00234	0.00535	CcSEcCtD
Carglumic Acid—Infestation—Methylprednisolone—multiple sclerosis	0.00234	0.00535	CcSEcCtD
Carglumic Acid—Bradycardia—Prednisolone—multiple sclerosis	0.00233	0.00533	CcSEcCtD
Carglumic Acid—Sweating increased—Betamethasone—multiple sclerosis	0.00233	0.00531	CcSEcCtD
Carglumic Acid—Sweating increased—Dexamethasone—multiple sclerosis	0.00233	0.00531	CcSEcCtD
Carglumic Acid—Anaemia—Mitoxantrone—multiple sclerosis	0.00225	0.00513	CcSEcCtD
Carglumic Acid—Asthenia—Cladribine—multiple sclerosis	0.00217	0.00495	CcSEcCtD
Carglumic Acid—Weight decreased—Betamethasone—multiple sclerosis	0.00216	0.00494	CcSEcCtD
Carglumic Acid—Weight decreased—Dexamethasone—multiple sclerosis	0.00216	0.00494	CcSEcCtD
Carglumic Acid—Bradycardia—Triamcinolone—multiple sclerosis	0.00214	0.0049	CcSEcCtD
Carglumic Acid—Bradycardia—Methylprednisolone—multiple sclerosis	0.00214	0.00489	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00212	0.00484	CcSEcCtD
Carglumic Acid—Diarrhoea—Cladribine—multiple sclerosis	0.00206	0.00472	CcSEcCtD
Carglumic Acid—Sweating increased—Prednisone—multiple sclerosis	0.00203	0.00463	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00201	0.00458	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—BCHE—multiple sclerosis	0.00199	0.00721	CbGpPWpGaD
Carglumic Acid—Infection—Mitoxantrone—multiple sclerosis	0.00197	0.0045	CcSEcCtD
Carglumic Acid—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00195	0.00446	CcSEcCtD
Carglumic Acid—Bradycardia—Dexamethasone—multiple sclerosis	0.00195	0.00444	CcSEcCtD
Carglumic Acid—Bradycardia—Betamethasone—multiple sclerosis	0.00195	0.00444	CcSEcCtD
Carglumic Acid—Abdominal pain—Azathioprine—multiple sclerosis	0.00194	0.00443	CcSEcCtD
Carglumic Acid—Body temperature increased—Azathioprine—multiple sclerosis	0.00194	0.00443	CcSEcCtD
Carglumic Acid—Skin disorder—Mitoxantrone—multiple sclerosis	0.00193	0.0044	CcSEcCtD
Carglumic Acid—Vomiting—Cladribine—multiple sclerosis	0.00192	0.00438	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00192	0.00438	CcSEcCtD
Carglumic Acid—Rash—Cladribine—multiple sclerosis	0.0019	0.00435	CcSEcCtD
Carglumic Acid—Dermatitis—Cladribine—multiple sclerosis	0.0019	0.00434	CcSEcCtD
Carglumic Acid—Anorexia—Mitoxantrone—multiple sclerosis	0.00189	0.00432	CcSEcCtD
Carglumic Acid—Headache—Cladribine—multiple sclerosis	0.00189	0.00432	CcSEcCtD
Carglumic Acid—Weight decreased—Prednisone—multiple sclerosis	0.00188	0.0043	CcSEcCtD
Carglumic Acid—Malnutrition—Methylprednisolone—multiple sclerosis	0.00183	0.00418	CcSEcCtD
Carglumic Acid—Dysgeusia—Triamcinolone—multiple sclerosis	0.0018	0.0041	CcSEcCtD
Carglumic Acid—Somnolence—Mitoxantrone—multiple sclerosis	0.00176	0.00403	CcSEcCtD
Carglumic Acid—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00172	0.00394	CcSEcCtD
Carglumic Acid—Bradycardia—Prednisone—multiple sclerosis	0.00169	0.00387	CcSEcCtD
Carglumic Acid—Diarrhoea—Azathioprine—multiple sclerosis	0.00168	0.00384	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00162	0.00371	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00157	0.00359	CcSEcCtD
Carglumic Acid—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00157	0.00358	CcSEcCtD
Carglumic Acid—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00157	0.00358	CcSEcCtD
Carglumic Acid—Vomiting—Azathioprine—multiple sclerosis	0.00156	0.00356	CcSEcCtD
Carglumic Acid—Pneumonia—Methotrexate—multiple sclerosis	0.00156	0.00356	CcSEcCtD
Carglumic Acid—Infestation—Methotrexate—multiple sclerosis	0.00155	0.00354	CcSEcCtD
Carglumic Acid—Infestation NOS—Methotrexate—multiple sclerosis	0.00155	0.00354	CcSEcCtD
Carglumic Acid—Rash—Azathioprine—multiple sclerosis	0.00155	0.00353	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00155	0.00353	CcSEcCtD
Carglumic Acid—Dermatitis—Azathioprine—multiple sclerosis	0.00155	0.00353	CcSEcCtD
Carglumic Acid—Headache—Azathioprine—multiple sclerosis	0.00154	0.00351	CcSEcCtD
Carglumic Acid—Infection—Triamcinolone—multiple sclerosis	0.00149	0.0034	CcSEcCtD
Carglumic Acid—Infection—Methylprednisolone—multiple sclerosis	0.00148	0.00339	CcSEcCtD
Carglumic Acid—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00146	0.00335	CcSEcCtD
Carglumic Acid—Skin disorder—Methylprednisolone—multiple sclerosis	0.00145	0.00331	CcSEcCtD
Carglumic Acid—Malnutrition—Prednisone—multiple sclerosis	0.00145	0.00331	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00145	0.0033	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00144	0.0033	CcSEcCtD
Carglumic Acid—Asthenia—Mitoxantrone—multiple sclerosis	0.00142	0.00325	CcSEcCtD
Carglumic Acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00136	0.0031	CcSEcCtD
Carglumic Acid—Infection—Dexamethasone—multiple sclerosis	0.00135	0.00308	CcSEcCtD
Carglumic Acid—Infection—Betamethasone—multiple sclerosis	0.00135	0.00308	CcSEcCtD
Carglumic Acid—Anaemia—Prednisone—multiple sclerosis	0.00134	0.00306	CcSEcCtD
Carglumic Acid—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00133	0.00304	CcSEcCtD
Carglumic Acid—Nervous system disorder—Betamethasone—multiple sclerosis	0.00133	0.00304	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00131	0.003	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00131	0.003	CcSEcCtD
Carglumic Acid—Anorexia—Dexamethasone—multiple sclerosis	0.00129	0.00296	CcSEcCtD
Carglumic Acid—Anorexia—Betamethasone—multiple sclerosis	0.00129	0.00296	CcSEcCtD
Carglumic Acid—Cardiac disorder—Methotrexate—multiple sclerosis	0.00129	0.00295	CcSEcCtD
Carglumic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.00126	0.00288	CcSEcCtD
Carglumic Acid—Rash—Mitoxantrone—multiple sclerosis	0.00125	0.00286	CcSEcCtD
Carglumic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.00125	0.00285	CcSEcCtD
Carglumic Acid—Headache—Mitoxantrone—multiple sclerosis	0.00124	0.00284	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00123	0.0028	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00122	0.00279	CcSEcCtD
Carglumic Acid—Malnutrition—Methotrexate—multiple sclerosis	0.00121	0.00277	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—APOE—multiple sclerosis	0.0012	0.00434	CbGpPWpGaD
Carglumic Acid—Dysgeusia—Methotrexate—multiple sclerosis	0.00119	0.00271	CcSEcCtD
Carglumic Acid—Body temperature increased—Triamcinolone—multiple sclerosis	0.00118	0.0027	CcSEcCtD
Carglumic Acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00118	0.0027	CcSEcCtD
Carglumic Acid—Decreased appetite—Betamethasone—multiple sclerosis	0.00118	0.0027	CcSEcCtD
Carglumic Acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.00118	0.0027	CcSEcCtD
Carglumic Acid—Infection—Prednisone—multiple sclerosis	0.00117	0.00268	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00117	0.00268	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00117	0.00268	CcSEcCtD
Carglumic Acid—Nervous system disorder—Prednisone—multiple sclerosis	0.00116	0.00265	CcSEcCtD
Carglumic Acid—Skin disorder—Prednisone—multiple sclerosis	0.00115	0.00262	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Prednisone—multiple sclerosis	0.00114	0.00261	CcSEcCtD
Carglumic Acid—Anorexia—Prednisone—multiple sclerosis	0.00113	0.00258	CcSEcCtD
Carglumic Acid—Anaemia—Methotrexate—multiple sclerosis	0.00112	0.00256	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00111	0.00254	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00111	0.00254	CcSEcCtD
Carglumic Acid—Asthenia—Triamcinolone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Body temperature increased—Dexamethasone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Body temperature increased—Betamethasone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Abdominal pain—Betamethasone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Asthenia—Methylprednisolone—multiple sclerosis	0.00107	0.00245	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—POMC—multiple sclerosis	0.00103	0.00373	CbGpPWpGaD
Carglumic Acid—Decreased appetite—Prednisone—multiple sclerosis	0.00103	0.00235	CcSEcCtD
Carglumic Acid—Rash—Prednisolone—multiple sclerosis	0.00103	0.00234	CcSEcCtD
Carglumic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.00103	0.00234	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00102	0.00234	CcSEcCtD
Carglumic Acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00102	0.00233	CcSEcCtD
Carglumic Acid—Headache—Prednisolone—multiple sclerosis	0.00102	0.00233	CcSEcCtD
Carglumic Acid—Infection—Methotrexate—multiple sclerosis	0.000982	0.00224	CcSEcCtD
Carglumic Acid—Asthenia—Betamethasone—multiple sclerosis	0.000974	0.00223	CcSEcCtD
Carglumic Acid—Asthenia—Dexamethasone—multiple sclerosis	0.000974	0.00223	CcSEcCtD
Carglumic Acid—Nervous system disorder—Methotrexate—multiple sclerosis	0.000969	0.00221	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000967	0.00221	CcSEcCtD
Carglumic Acid—Skin disorder—Methotrexate—multiple sclerosis	0.00096	0.00219	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000955	0.00218	CcSEcCtD
Carglumic Acid—Vomiting—Triamcinolone—multiple sclerosis	0.000952	0.00217	CcSEcCtD
Carglumic Acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000949	0.00217	CcSEcCtD
Carglumic Acid—Rash—Triamcinolone—multiple sclerosis	0.000944	0.00216	CcSEcCtD
Carglumic Acid—Dermatitis—Triamcinolone—multiple sclerosis	0.000943	0.00215	CcSEcCtD
Carglumic Acid—Anorexia—Methotrexate—multiple sclerosis	0.000942	0.00215	CcSEcCtD
Carglumic Acid—Rash—Methylprednisolone—multiple sclerosis	0.000942	0.00215	CcSEcCtD
Carglumic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000941	0.00215	CcSEcCtD
Carglumic Acid—CPS1—Metabolism—ALB—multiple sclerosis	0.000938	0.0034	CbGpPWpGaD
Carglumic Acid—Headache—Triamcinolone—multiple sclerosis	0.000938	0.00214	CcSEcCtD
Carglumic Acid—Headache—Methylprednisolone—multiple sclerosis	0.000935	0.00214	CcSEcCtD
Carglumic Acid—Abdominal pain—Prednisone—multiple sclerosis	0.000935	0.00214	CcSEcCtD
Carglumic Acid—Body temperature increased—Prednisone—multiple sclerosis	0.000935	0.00214	CcSEcCtD
Carglumic Acid—Diarrhoea—Betamethasone—multiple sclerosis	0.000929	0.00212	CcSEcCtD
Carglumic Acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.000929	0.00212	CcSEcCtD
Carglumic Acid—Somnolence—Methotrexate—multiple sclerosis	0.000879	0.00201	CcSEcCtD
Carglumic Acid—Vomiting—Betamethasone—multiple sclerosis	0.000863	0.00197	CcSEcCtD
Carglumic Acid—Vomiting—Dexamethasone—multiple sclerosis	0.000863	0.00197	CcSEcCtD
Carglumic Acid—Decreased appetite—Methotrexate—multiple sclerosis	0.000859	0.00196	CcSEcCtD
Carglumic Acid—Rash—Dexamethasone—multiple sclerosis	0.000856	0.00196	CcSEcCtD
Carglumic Acid—Rash—Betamethasone—multiple sclerosis	0.000856	0.00196	CcSEcCtD
Carglumic Acid—Dermatitis—Dexamethasone—multiple sclerosis	0.000855	0.00195	CcSEcCtD
Carglumic Acid—Dermatitis—Betamethasone—multiple sclerosis	0.000855	0.00195	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000853	0.00195	CcSEcCtD
Carglumic Acid—Headache—Dexamethasone—multiple sclerosis	0.000851	0.00194	CcSEcCtD
Carglumic Acid—Headache—Betamethasone—multiple sclerosis	0.000851	0.00194	CcSEcCtD
Carglumic Acid—Asthenia—Prednisone—multiple sclerosis	0.000848	0.00194	CcSEcCtD
Carglumic Acid—Diarrhoea—Prednisone—multiple sclerosis	0.000809	0.00185	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000808	0.00185	CcSEcCtD
Carglumic Acid—Abdominal pain—Methotrexate—multiple sclerosis	0.000781	0.00178	CcSEcCtD
Carglumic Acid—Body temperature increased—Methotrexate—multiple sclerosis	0.000781	0.00178	CcSEcCtD
Carglumic Acid—Vomiting—Prednisone—multiple sclerosis	0.000752	0.00172	CcSEcCtD
Carglumic Acid—Rash—Prednisone—multiple sclerosis	0.000746	0.0017	CcSEcCtD
Carglumic Acid—Dermatitis—Prednisone—multiple sclerosis	0.000745	0.0017	CcSEcCtD
Carglumic Acid—Headache—Prednisone—multiple sclerosis	0.000741	0.00169	CcSEcCtD
Carglumic Acid—Asthenia—Methotrexate—multiple sclerosis	0.000709	0.00162	CcSEcCtD
Carglumic Acid—Diarrhoea—Methotrexate—multiple sclerosis	0.000676	0.00154	CcSEcCtD
Carglumic Acid—Vomiting—Methotrexate—multiple sclerosis	0.000628	0.00144	CcSEcCtD
Carglumic Acid—Rash—Methotrexate—multiple sclerosis	0.000623	0.00142	CcSEcCtD
Carglumic Acid—Dermatitis—Methotrexate—multiple sclerosis	0.000623	0.00142	CcSEcCtD
Carglumic Acid—Headache—Methotrexate—multiple sclerosis	0.000619	0.00141	CcSEcCtD
